Abstract:Heart failure (HF) represents the advanced stage of several cardiovascular disorders. This study aimed to build an alternative splicing regulatory network and identify potential splicing factors involved in HF utilizing RNA-seq data and machine learning algorithms. We performed bioinformatics analysis on RNA-seq datasets containing samples from HF patients and normal individuals to obtain gene expression matrices and identify differently regulated alternative splicing events in HF. By calculating percent spliced-in (PSI) value, we identified 4055 abnormal alternative splicing events of 3142 genes in HF. These genes were significantly enriched in PPAR signaling, regulation of actin cytoskeleton, and muscle contraction. Interestingly, based on abnormal alternative splicing events, two distinct clusters of HF patients with distinct molecular mechanisms and pathways were identified using unsupervised clustering. Additionally, we built a regulatory network consisting of heart failure-related alternative splicing and splicing factors. Subsequently, we identify 203 HF specific pairs between splicing factors and alternative splicing events. Four splicing factors (RBM5, ZRANB2, HnRNPF, and HnRNPA0) were found using LASSO and SVM-RFE algorithms, their expression patterns were confirmed in two other microarray datasets. Our study clarifies involvement of splicing factors and alternative splicing events in HF by thoroughly analyzing RNA-seq data with machine learning methods. The findings may advance our understanding of the regulatory systems underlying biological processes associated with heart failure by providing candidates for further investigation and markers for diagnostic and therapeutic purposes.

Development and Disease-Specific Regulation of RNA Splicing in Cardiovascular System

Therapeutic potential of alternative splicing in cardiovascular diseases

Identification of alternative splicing regulatory patterns and characteristic splicing factors in heart failure using RNA-seq data and machine learning

RNA Structures in Alternative Splicing and Back‐splicing

Alternative Splicing As a Biomarker and Potential Target for Drug Discovery

Alternative splicing and related RNA binding proteins in human health and disease

The Expanding Role of Alternative Splicing in Vascular Smooth Muscle Cell Plasticity

Post-Transcriptional Modification by Alternative Splicing and Pathogenic Splicing Variants in Cardiovascular Development and Congenital Heart Defects

<scp>RNA</scp> structures in alternative splicing and back‐splicing

RNA Splicing: A Versatile Regulatory Mechanism in Pediatric Liver Diseases

Research Progresses of Regulation of Alternative Splicing

CaMKIIδ Splice Variants in the Healthy and Diseased Heart

RBFox1-mediated RNA Splicing Regulates Cardiac Hypertrophy and Heart Failure.

RNA structure in alternative splicing regulation: from mechanism to therapy

Alternative pre-mRNA splicing in stem cell function and therapeutic potential: A critical review of current evidence

The role of alternative splicing in human cancer progression.

Alternative splicing regulates vesicular trafficking genes in cardiomyocytes during postnatal heart development

The alternative splicing landscape of infarcted mouse heart identifies isoform level therapeutic targets

Nanopore long-read RNA sequencing reveals functional alternative splicing variants in human vascular smooth muscle cells

Alternative splicing of gene transcription and its progress in clinical pharmacology

Alternative Splicing: A New Cause and Potential Therapeutic Target in Autoimmune Disease